HOME >> MEDICINE >> NEWS
VELCADE (Bortezomib) receives European marketing authorisation

Brussels, Belgium, {27 April 2004} Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced that the European Commission has issued a positive decision for VELCADE, a new treatment for multiple myeloma, a form of blood cancer. The novel drug is indicated to treat multiple myeloma patients who have received at least two prior therapies and demonstrated disease progression on their last therapy.

VELCADE is a completely new approach to treating multiple myeloma that acts on a unique target in cells called the proteasome.

Multiple myeloma is the second most common blood cancer, representing approximately one percent of all cancers and two percent of all cancer deaths. Worldwide in 2000, there were 73,943 cases of multiple myeloma and 57,370 deaths. In Europe there were approximately 19,000 cases in 2000 and just under 15,000 deaths (1). Only 30 percent of multiple myeloma patients survive longer than five years (2).

"The approval of VELCADE by the European Agency for the Evaluation of Medicinal Products (EMEA) represents a breakthrough in our continued battle against multiple myeloma" said Professor Mario Boccadoro, Professor of Hematology, Director of the Section of Hematology, University of Torino, Italy. "With its new and unique mechanism of action, VELCADE represents a new treatment option for patients".

Clinical results from a phase II study have shown that VELCADE can slow, reverse or halt progression of disease in patients who failed on two or more treatments, potentially helping patients live longer. In a study of 202 patients with relapsed and refractory multiple myeloma and who progressed after initial treatments, 35% responded to VELCADE and 10% had a complete remission. This pivotal study was the basis for an accelerated review of VELCADE by U.S. Food and Drug Administration (FDA) and approval within four months of the New Drug Application submission on 13 May 2003.

"We are deli
'"/>

Contact: Eva Reynolds
eva_reynolds@uk.bm.com
44-20-7831-6262
Burson-Marsteller
28-Apr-2004


Page: 1 2 3

Related medicine news :

1. VELCADE(TM) data confirms long-term survival
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
10. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
11. Pfizers antifungal medicine VFEND receives FDA approval

Post Your Comments:
(Date:5/6/2015)... Los Angeles, CA (PRWEB) May 06, 2015 ... titled “16 Celebrities on Plastic Surgery ,” compiled ... of celebs includes Jennifer Aniston, pop singer Iggy Azalea, ... quote indicates their sentiments about having plastic surgery ... a statement about society and its expectations of youth ...
(Date:5/6/2015)... May 06, 2015 Chesapeake Regional ... state of Virginia to acquire Intuitive Surgical, Inc.’s ... The system upgrade includes enhanced surgical technique capabilities, ... procedures across a wide spectrum of specialties. Its ... pain and quicker recovery times. , “As the ...
(Date:5/6/2015)... 2015 TMG Health, the leading national ... Advantage, Medicare Part D and Managed Medicaid markets, was ... Team category at the BCI North America Awards, a ... the outstanding contribution of business continuity professionals and organizations ... including the USA and Canada. The North America Awards ...
(Date:5/6/2015)... Inversion Studios, a full-service training center ... classes, provides personalized individual instruction and now offers ... new Pilates Ring magic circle. , Inversion Studios ... more centered and graceful, Inversion Studios and its ... healthy fitness through yoga and Pilates. With a ...
(Date:5/6/2015)... San Jose, California (PRWEB) May 06, 2015 ... sales of hand sanitizers are increasing, driven by the ... in preventing the spread of contagious diseases. Hand washing ... a result of consumer apprehension over contracting infections. Periodic ... well as the recent Ebola virus disease ...
Breaking Medicine News(10 mins):Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4
(Date:5/6/2015)... 2015  Rigrodsky & Long, P.A.: , Do you, ... AERI )? , Did you purchase your shares between ... you lose money in your investment in Aerie Pharmaceuticals, Inc.? ... Rigrodsky & Long, P.A. , including former Special Assistant ... complaint has been filed in the United States District Court for ...
(Date:5/6/2015)... 2015  Membership in Medicare Supplement plans continued ... Business Strategy report released by Mark Farrah Associates ... or Med Supp plans, covered approximately 11.2 million ... increase from 2013. Between 2013 and 2014, enrollment ... lives.  Though UnitedHealth was the segment growth leader, ...
(Date:5/6/2015)... 6, 2015  LumiThera Inc., a medical device company ... for ocular disorders and disease, today announced Retired Congressman ... Advisory Board to assist in the company,s mission to ... Dicks was the U.S. Representative for Washington,s ... 2013. He is a member of the Democratic Party. ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2
Cached News: